Thursday, September 24, 2009 7:08:41 PM
http://stockcharts.com/charts/gallery.html?MYGN
High pole warning 9/23/09 on P & F chart, "The high pole warning is given when a chart rises above a previous high by at least 3 boxes but then reverses to give back at least 50% of the rise. The reversal implies that the demand that was making the prices rise has given way to supply pressure. The pattern is a warning that lower prices could be seen in the future." from "chartschool" on stockcharts. com
On regular stockcharts. com chart, RSI @ 35, not in oversold territory yet; MACD rolling over but still in positive territory and Full STO <20, so that is "oversold," but it does not mean that MYGN could not still go lower. MA(50) $27.89, which it has crossed today, which is negative.
$30.63 (Q2-09 low)
$28.22 (pre move high)
$28.04
Resistance:
@ $26.52:
Support
$25.88 (which was the price before MYGN popped to $30.89),
$25.04 and
$24.36, which as of this time is the Q3-2009 low.
Recent MYGN News
- What We Don’t Know Can Hurt: New Cancer Risk Survey from Myriad Genetics Reveals Serious Knowledge Gaps About Breast Density and Cancer Risk • GlobeNewswire Inc. • 07/17/2024 12:00:00 PM
- Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing • GlobeNewswire Inc. • 07/11/2024 01:00:00 PM
- Myriad Genetics Announces Second Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date • GlobeNewswire Inc. • 07/09/2024 01:00:00 PM
- Myriad Genetics Earns 2024 Great Place To Work® Certification™ • GlobeNewswire Inc. • 07/02/2024 01:00:00 PM
- Survey Suggests Increased Attention on Mental Health Warranted in the Run-Up to the Election • GlobeNewswire Inc. • 06/24/2024 08:05:00 PM
- Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries • GlobeNewswire Inc. • 06/11/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 08:15:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:54:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:54:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:54:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:54:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:53:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:53:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:53:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 08:06:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 09:57:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/04/2024 02:32:30 PM
- Myriad Genetics Launches New Universal Plus Panel for Foresight® Carrier Screen • GlobeNewswire Inc. • 06/04/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 08:06:29 PM
- Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool • GlobeNewswire Inc. • 06/03/2024 08:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2024 05:48:33 PM
- QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications • GlobeNewswire Inc. • 05/30/2024 09:55:30 PM
- Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual Meeting • GlobeNewswire Inc. • 05/23/2024 10:00:00 PM
- New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer • GlobeNewswire Inc. • 05/16/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 09:49:23 PM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM